TGT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TGT is not a good buy right now for an impatient investor. The stock is bouncing (regular session +2.56%) but the trend evidence is still mixed-to-weak (MACD below zero), fundamentals in the latest quarter are declining YoY, and options flow shows elevated hedging/uncertainty. I would HOLD/AVOID initiating a new position today unless you are specifically trading a short-term catalyst (Investor Day / CEO transition).
Price/levels: Post-market ~105.25, sitting just below the pivot (106.189). Immediate support is S1 ~102.04 (then S2 ~99.47); near-term resistance is R1 ~110.34 (then R2 ~112.91). This places TGT in a range where upside exists, but it must reclaim/hold above ~106 to improve the short-term setup. Momentum: MACD histogram is -0.931 (below zero) and only "negatively contracting"—bearish momentum is easing, but not reversed. RSI(6) ~52.29 is neutral (no strong edge). Moving averages are converging, consistent with rangebound/choppy conditions rather than a clean uptrend. Pattern/stat tilt: Similar-pattern study implies modest upside bias (next month +0.59% expected) but not strong enough to override weak momentum.
Intellectia Proprietary Trading Signals
shows continued deterioration: revenue, EPS, net income, and gross margin all down YoY—hard to justify an aggressive buy without signs of inflection.
with MACD negative—technical trend has not cleanly flipped bullish.
Latest quarter: 2026/Q3. Revenue fell to $25.27B (-1.55% YoY). Net income declined to $689M (-19.32% YoY). EPS fell to $1.51 (-18.38% YoY). Gross margin slipped to 25.66% (-1.00% YoY). Overall: weakening profitability and margins alongside slightly negative sales growth, indicating the turnaround is not yet showing up in reported results.
Recent trend: Ratings/targets have been pressured over the last few months (many Neutral/Market Perform/In Line ratings with multiple price-target cuts into Nov–Dec 2025). On 2026-01-27, Wolfe upgraded TGT from Underperform to Peer Perform (no PT), which is a marginal sentiment improvement ahead of Investor Day. Price targets mentioned: Deutsche Bank Hold $108 (Jan 8, 2026); Evercore cut to $95; Citi cut to $89; Piper cut to $85; BMO cut to $90; Bernstein cut to $80; Wolfe previously $81 before upgrading. Wall Street pros: asset/real-estate value support, potential operational improvement, catalyst from Investor Day/leadership change. Wall Street cons: negative comps/market-share challenges, margin pressure, execution/supply chain investment needs, and reduced confidence reflected by multiple lowered targets.
